Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Safety and Efficacy of Vedolizumab in Indian Patients With Ulcerative Colitis and Crohn's Disease

NCT04804540 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04804540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04804540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Safety and Efficacy of Vedolizumab in Indian Patients With Ulcerative Colitis and Crohn's Disease
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
December 8, 2021
Completion date
February 2, 2024
Enrollment
150 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis